BlackRock Fund Advisors’s Albany Molecular Research Inc AMRI Stock Holding History
Bought
Maintained
Sold
Other funds holding AMRI
PIP
ACM
RHJA
AAM
BlackRock Fund Advisors's AMRI Position: Q4 2016 in Review
BlackRock Fund Advisors increased its Albany Molecular Research Inc (AMRI) stake by 16% in Q4 2016, buying an estimated $6.11M and bringing the position to 2,599,221 shares worth $48.8M. The position accounts for 0.01% of the portfolio, ranked #1701.
BlackRock Fund Advisors first reported a position in AMRI in Q2 2013 and has held it in 15 quarters since. 133 funds tracked by Wall St. Rank hold AMRI as of Q4 2016.
- BlackRock Fund Advisors held 2,599,221 shares of Albany Molecular Research Inc worth $48.8M as of Q4 2016.
- BlackRock Fund Advisors bought 359,629 Albany Molecular Research Inc shares in Q4 2016, an estimated $6.11M.
- Albany Molecular Research Inc made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1701 holding.
- BlackRock Fund Advisors first reported a position in Albany Molecular Research Inc in Q2 2013 and has held it in 15 quarters since.
- 133 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q4 2016.
Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.